专利名称:COMPOSITIONS AND METHODS FOR THE
TREATMENT OF HEMOGLOBINOPATHIES
发明人:BENDER, Michael A.,GROUDINE, Mark
T.,STODDARD, Barry L.,TAKEUCHI, Ryo
申请号:EP17178186.7申请日:20130222公开号:EP3272356A1公开日:20180124
专利附图:
摘要:Provided are compositions and methods for the treatment of
hemoglobinopathies such as thalassemias and sickle cell disease. Compositions and
methods include one or more endonuclease(s) or endonuclease fusion protein(s),including one or more homing endonuclease(s) and/or homing endonuclease fusionprotein(s) and/or CRISPR endonuclease(s) and/or CRISPR endonuclease fusion protein(s):(a) to disrupt a Bcl1 1a coding region; (b) to disrupt a Bcl1 1a gene regulatory region; (c)to modify an adult human β-globin locus; (d) to disrupt a HbF silencing DNA regulatoryelement or pathway, such as a Bcl1 1a-regulated HbF silencing region; (e) to mutate oneor more γ-globin gene promoter(s) to achieve increased expression of a γ-globin gene; (f)to mutate one or more δ-globin gene promoter(s) to achieve increased expression of aδ-globin gene; and/or (g) to correct one or more β-globin gene mutation(s).
申请人:Fred Hutchinson Cancer Research Center
地址:1100 Fairview Avenue North Seattle, WA 98109 US
国籍:US
代理机构:Griffin, Philippa Jane
更多信息请下载全文后查看
因篇幅问题不能全部显示,请点此查看更多更全内容
Copyright © 2019- zicool.com 版权所有 湘ICP备2023022495号-2
违法及侵权请联系:TEL:199 1889 7713 E-MAIL:2724546146@qq.com
本站由北京市万商天勤律师事务所王兴未律师提供法律服务